Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Eugene Hoshiko / AP

Japan's SoftBank today announced a $93 billion first closing for its long-awaited Vision Fund (with plans to be at $100 billion within six months), which will invest globally in both private and public technology companies.

Why it matters: This is the largest private equity fund ever raised, let alone one to focus exclusively on technology companies.

The unveil: SoftBank timed today's news to President Trump's visit to Saudi Arabia, which committed $45 billion via one of its sovereign wealth funds. Plans for Vision Fund were underway well before last November's election, but Trump took credit after SoftBank chief Masayoshi Son visited Trump Tower and promised that half the money would be invested in the U.S. and that it would create 50,000 new jobs.

Investment strategy: Vision Fund will take both majority and minority equity positions, as Axios previously reported. It also has the right to acquire certain existing SoftBank investments, including deals for Guardant Health, Intelsat, NVIDIA, OneWeb, SoFi and nearly 25% of its stake in British chipmaker ARM.

Investors: Beyond the commitments from Saudi and SoftBank itself ($25 billion ― $8.2 billion of which comes via the in-kind commitment of ARM shares), other investors in Vision Fund include Apple, Sharp Electronics, Foxconn Technology Group, Qualcomm, Sharp Corp. and a sovereign wealth fund of the United Arab Emirates.

More details, per a source familiar with the situation:

  • Saudi Arabia's Public Investment Fund has the right to refrain from participating in deals of over a certain size.
  • It also has the right to sit in on deal meetings, but it doesn't have a vote.
  • The above negotiations delayed the initial close, which originally had been expected to occur months ago.
  • Because of potential conflicts of interest related to existing investments in Uber (Saudi PIF) and Didi (SoftBank), Vision Fund will not participate ride-hail deals anywhere.
  • SoftBank continues to seek the elusive $100 billion mark, in part, because Son has a preference for big, round numbers (seriously). The fact that hitting such a figure could remain six months off, however, indicates that the extra $7 billion remains elusive.

Go deeper

Ina Fried, author of Login
33 mins ago - Technology

Epic's long game against Apple

Illustration: Sarah Grillo/Axios

Epic's Apple lawsuit is costing the company dearly, but the game developer has its eye on a valuable long-term goal: prying tomorrow's virtual worlds loose from the grip of app store proprietors like Apple.

Between the lines: Epic isn't spending a fortune in legal fees and foregoing a ton of revenue just to shave some costs off in-app purchases on today's phones. Rather, it's planning for a future of creating virtual universes via augmented and virtual reality — without having to send a big chunk of their economies to Apple or Google.

Updated 38 mins ago - Health

The race to avoid a possible "monster" COVID variant

Illustration: Rae Cook/Axios

Slow global COVID-19 vaccination rates are raising concerns that worse variants of the coronavirus could be percolating, ready to rip into the world before herd immunity can diminish their impact.

Why it matters: The U.S. aims to at least partially vaccinate 70% of adults by July 4, a move expected to accelerate the current drop of new infections here. But variants are the wild card, and in a global pandemic where only about 8% of all people have received one dose, the virus will continue mutating unabated.

Caitlin Owens, author of Vitals
1 hour ago - Health

Democrats are still looking for a plan on drug prices

Illustration: Rae Cook/Axios

Democrats have no workable plan to tackle the cost of prescription drugs, even with full control of Washington and after campaigning on the issue for years.

The picture: Voters still care about the cost of drugs, but Democrats don't have a feasible legislative strategy yet — or an agreed-upon policy to fit into a legislative strategy.